Search for a trial

A phase 1, randomized, observer-blind study to compare the safety, reactogenicity, and
Immunogenicity of Ad26.COV2.S at a single Dose of 5x10^10 vp in 2 different volumes in healthy adults

Ad26.COV2.S, also referred to as a *study vaccine* in this document, is a COVID 19 vaccine. In this study, the formation of antibodies against the coronavirus is compared at two different dosing volumes. In addition, it will be investigated if it is…